TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section
Brief Summary: Postpartum hemorrhage (PPH) is a common complication of childbirth and a leading cause of maternal morbidity and mortality. The prompt and effective treatment of subjects with PPH would reduce operation risks. Hence in this study, the efficacy of Oxytocin and Carbetocin was compared in prevention of postpartum hemorrhage after cesarean sections.


Options:
A: Arm Label: Carbetocin 10mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 20mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 40mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 60mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 80mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 100mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 120mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 140mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin 100mcg, Carbetocin 10mcg, Carbetocin 120mcg, Carbetocin 140mcg, Carbetocin 20mcg, Carbetocin 40mcg, Carbetocin 60mcg, Carbetocin 80mcg
B: Arm Label: Oxytocin; Type: EXPERIMENTAL; Interventions: Drug: Oxytocin | Arm Label: Carbetocin; Type: EXPERIMENTAL; Interventions: Drug: Carbetocin | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin
C: Arm Label: tranexamic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: transamin | Arm Label: saline; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: transamin; Assigned to Arm(s): tranexamic acid
D: Arm Label: Oxytocin in Uniject; Type: EXPERIMENTAL; Interventions: Other: Oxytocin in Uniject | Arm Label: PPH Treatment Only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Oxytocin in Uniject; Assigned to Arm(s): Oxytocin in Uniject

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Protection of Heart, Brain and Kidney by Remote Ischemic Preconditioning in Patients Undergoing Transcatheter Aortic Valve Implantation - a Randomized, Single-blind Study
Brief Summary: Transcatheter aortic valve implantation (TAVI) has rapidly been adopted into clinical practice, but concerns have been raised regarding periprocedural complications like e.g. myocardial injury, stroke or acute kidney injury. Remote ischemic preconditioning (RIPC) with upper limb ischemia/reperfusion provides perioperative myocardial protection in patients undergoing elective coronary artery bypass surgery. The present study assesses protection of heart, brain and kidney by RIPC in patients undergoing TAVI. The study also addresses safety and clinical outcome.


Options:
A: Arm Label: RIPC group; Type: EXPERIMENTAL; Interventions: Procedure: Remote ischemic preconditioning, Procedure: Carotid Artery Stenting | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Carotid Artery Stenting | Arm Label: Sham RIPC group; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham remote ischemic preconditioning, Procedure: Carotid Artery Stenting | Intervention Type: PROCEDURE; Name: Remote ischemic preconditioning; Assigned to Arm(s): RIPC group | Intervention Type: PROCEDURE; Name: Sham remote ischemic preconditioning; Assigned to Arm(s): Sham RIPC group | Intervention Type: PROCEDURE; Name: Carotid Artery Stenting; Assigned to Arm(s): Control group, RIPC group, Sham RIPC group
B: Arm Label: Remote ischemic preconditioning (RIPC); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Remote ischemic preconditioning (RIPC) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Placebo | Intervention Type: PROCEDURE; Name: Remote ischemic preconditioning (RIPC); Assigned to Arm(s): Remote ischemic preconditioning (RIPC) | Intervention Type: PROCEDURE; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Thrombolysis + Remote perconditioning; Type: EXPERIMENTAL; Interventions: Procedure: Thrombolysis + remote perconditioning | Arm Label: Thrombolysis; Type: ACTIVE_COMPARATOR; Interventions: Drug: Actilyse | Intervention Type: DRUG; Name: Actilyse; Assigned to Arm(s): Thrombolysis | Intervention Type: PROCEDURE; Name: Thrombolysis + remote perconditioning; Assigned to Arm(s): Thrombolysis + Remote perconditioning
D: Arm Label: remote ischemic preconditioning; Type: EXPERIMENTAL; Interventions: Procedure: remote ischemic preconditioning | Arm Label: placebo remote ischemic preconditioning; Type: SHAM_COMPARATOR; Interventions: Procedure: sham remote ischemic preconditioning | Intervention Type: PROCEDURE; Name: remote ischemic preconditioning; Assigned to Arm(s): remote ischemic preconditioning | Intervention Type: PROCEDURE; Name: sham remote ischemic preconditioning; Assigned to Arm(s): placebo remote ischemic preconditioning

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Is the 0.018-inch or the 0.022-inch Bracket Slot System More Effective in Orthodontic Treatment? A Randomized Clinical Trial.
Brief Summary: The purpose of this study is to compare the 0.018-inch and 0.022-inch bracket slot systems to determine which is more effective for orthodontic treatment .


Options:
A: Arm Label: OrthoAccel Device; Type: EXPERIMENTAL; Interventions: Device: OrthoAccel Device | Arm Label: Sham Device (inactive device); Type: SHAM_COMPARATOR; Interventions: Device: Sham Device | Intervention Type: DEVICE; Name: OrthoAccel Device; Assigned to Arm(s): OrthoAccel Device | Intervention Type: DEVICE; Name: Sham Device; Assigned to Arm(s): Sham Device (inactive device)
B: Arm Label: 0.018 bracket slot system; Type: EXPERIMENTAL; Interventions: Device: Orthodontic bracket slot system | Arm Label: 0.022 bracket slot system; Type: ACTIVE_COMPARATOR; Interventions: Device: Orthodontic bracket slot system | Intervention Type: DEVICE; Name: Orthodontic bracket slot system; Assigned to Arm(s): 0.018 bracket slot system, 0.022 bracket slot system
C: Arm Label: Conventional Decrowding; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Low Level Laser Therapy; Type: EXPERIMENTAL; Interventions: Radiation: low level laser therapy | Intervention Type: RADIATION; Name: low level laser therapy; Assigned to Arm(s): Low Level Laser Therapy
D: Arm Label: AcceleDent vibrational device; Type: EXPERIMENTAL; Interventions: Device: AcceleDent vibrational device | Arm Label: Sham AcceleDent device; Type: SHAM_COMPARATOR; Interventions: Device: Sham AcceleDent device | Arm Label: Fixed appliance only; Type: ACTIVE_COMPARATOR; Interventions: Other: Fixed appliance only | Intervention Type: DEVICE; Name: AcceleDent vibrational device; Assigned to Arm(s): AcceleDent vibrational device | Intervention Type: DEVICE; Name: Sham AcceleDent device; Assigned to Arm(s): Sham AcceleDent device | Intervention Type: OTHER; Name: Fixed appliance only; Assigned to Arm(s): Fixed appliance only

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
Brief Summary: Determine if riluzole shows evidence of efficacy, safety, and tolerability targeting drug-refractory irritability (DRI) in persons with autism spectrum disorders (ASD).


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vasopressin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vasopressin | Intervention Type: DRUG; Name: Vasopressin; Assigned to Arm(s): Vasopressin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Atomoxetine; Type: EXPERIMENTAL; Interventions: Drug: Atomoxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Atomoxetine; Assigned to Arm(s): Atomoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: methylphenidate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: guanfacine; Assigned to Arm(s): N/A
D: Arm Label: Riluzole; Type: EXPERIMENTAL; Interventions: Drug: Riluzole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: DRUG; Name: Riluzole; Assigned to Arm(s): Riluzole | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Multiple Behaviour Programme to Prevent and Manage Diarrhoea Among Children Under-five in Lusaka, Zambia
Brief Summary: Control of diarrhoeal disease requires a comprehensive package of preventive and curative interventions. in Zambia, the Programme for Awareness and Elimination of Diarrhoea (PAED) aims to reduce child deaths by combating diarrhoea in Lusaka province, Zambia. The behaviour change component of the PAED programme seeks to change behaviours important for diarrhoea prevention (handwashing with soap and exclusive breastfeeding) and improved treatment outcomes (use of oral rehydration solution (ORS) and zinc in home management of child diarrhoea).

The study aims to evaluate the feasibility of implementing a multiple behaviour change community programme to tackle diarrhoeal disease in children under-five and to assess the impact of this programme on practice of the target behaviours by caregivers of children under-five. The research questions will be answered through a a two-arm cluster-randomised trial (eight clusters per study arm).


Options:
A: Arm Label: Community behaviour change campaign; Type: EXPERIMENTAL; Interventions: Behavioral: Community behaviour change campaign | Arm Label: No community behaviour change campaign; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Community behaviour change campaign; Assigned to Arm(s): Community behaviour change campaign
B: Arm Label: visit with grandmother; Type: EXPERIMENTAL; Interventions: Behavioral: counseling sessions | Arm Label: visit without grandmother; Type: EXPERIMENTAL; Interventions: Behavioral: counseling sessions | Arm Label: no visit with grandmother; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: no visit without grandmother; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: counseling sessions; Assigned to Arm(s): visit with grandmother, visit without grandmother
C: Arm Label: Breast feeding optimization; Type: EXPERIMENTAL; Interventions: Behavioral: Breast feeding optimization, Behavioral: Usual care | Arm Label: Usual/routine care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Breast feeding optimization; Assigned to Arm(s): Breast feeding optimization | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Breast feeding optimization, Usual/routine care
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Exercise, and Breastfeeding Intervention | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Diet, Exercise, and Breastfeeding Intervention; Assigned to Arm(s): Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Implementation and Evaluation of the OB Nest Project at the Point of Care: Redefining Continuity of Care for Expectant Mothers.
Brief Summary: The study defines a new model of prenatal care called OB Nest which will be compared to the traditional model of prenatal care. OB nest is intended to create an experience for patients that feels more connected and patient-centered, allowing the patient to visit the clinic less frequently while offering increased communication with the OB nurses and providers through new tools provided to the patient. The goal of the project is to promote patient-centered care through a new prenatal care program based on constant and direct support from a nursing team, meeting the on-demand needs of expecting mothers as they rise, and as thus, redesigning the need and timing of on-site appointment with providers. Pregnant women randomized to the OB Nest cohort will see the number of pre-planned visits with their providers decreased and replaced with more direct and constant support and interaction with an assigned nursing team.


Options:
A: Arm Label: Midwife-led continuity of care; Type: N/A; Interventions: Behavioral: Midwife-led continuity of care | Arm Label: Regular care; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Midwife-led continuity of care; Assigned to Arm(s): Midwife-led continuity of care
B: Arm Label: OB Nest; Type: EXPERIMENTAL; Interventions: Other: OB Nest | Arm Label: Traditional Prenatal care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: OB Nest; Assigned to Arm(s): OB Nest
C: Arm Label: Continuity of midwifery care; Type: OTHER; Interventions: Procedure: Continuity of midwifery care | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Continuity of midwifery care; Assigned to Arm(s): Continuity of midwifery care
D: Arm Label: ChroPreg; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ChroPreg + standard care | Arm Label: Standard care alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ChroPreg + standard care; Assigned to Arm(s): ChroPreg

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An International Multicenter Clustered Randomized Controlled Trial to imProve Treatment With AntiCoagulanTs in Patients With Atrial Fibrillation.
Brief Summary: To determine whether a comprehensive evaluation and customized multilevel educational interventions will increase the rate of use of oral anticoagulants and the adherence and persistence of use in patients with atrial fibrillation. Our hypothesis is that there will be differences in the use of oral anticoagulants and the persistence in patients between the control and interventional group. There will be a greater change in the use of oral anticoagulants over one year in the cohort in the intervention sites than the control sites. This will be due to two factors: greater initiation of oral anticoagulants among patients not treated at baseline and greater persistence of treatment for those on treatment at baseline


Options:
A: Arm Label: Internet-Based integrated-management Program; Type: EXPERIMENTAL; Interventions: Other: Internet-Based integrated-management Program | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Control group | Intervention Type: OTHER; Name: Internet-Based integrated-management Program; Assigned to Arm(s): Internet-Based integrated-management Program | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group
B: Arm Label: Specialized AF-clinic; Type: EXPERIMENTAL; Interventions: Other: Specialized outpatient AF Clinic | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: Specialized outpatient AF Clinic; Assigned to Arm(s): Specialized AF-clinic | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse-coordinated integrated care model for AF | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Nurse-coordinated integrated care model for AF; Assigned to Arm(s): Intervention group
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Educational Intervention | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Educational Intervention; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The effect of clamping the indwelling urethral catheter before removal is an unsettled issue in clinical practice. No studies have done before in the patients with gynecologic cancers who received radical hysterectomy. We hypothesized that clamping the catheter would decrease the rate of recatheterization. In addition, the feeling of urination during clamping is correlated with lower rate of recatheterization after removal.


Options:
A: Arm Label: clamping; Type: EXPERIMENTAL; Interventions: Procedure: to clamp or release the catheter for 2 days before removal | Arm Label: no clamping; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: to clamp or release the catheter for 2 days before removal; Assigned to Arm(s): clamping
B: Arm Label: A B C; Type: EXPERIMENTAL; Interventions: Procedure: on Foley time | Intervention Type: PROCEDURE; Name: on Foley time; Assigned to Arm(s): A B C
C: Arm Label: 24 hour postop catheter removal; Type: EXPERIMENTAL; Interventions: Drug: Prazosin given 6 hours prior to catheter removal in the 24 hour group | Arm Label: 72 hour postoperative catheter removal; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Prazosin given 6 hours prior to catheter removal in the 24 hour group; Assigned to Arm(s): 24 hour postop catheter removal
D: Arm Label: Foley; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: No Foley; Type: ACTIVE_COMPARATOR; Interventions: Other: No Foley | Intervention Type: OTHER; Name: No Foley; Assigned to Arm(s): No Foley

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Chest Compression and Sustained Inflation for Asystole or Bradycardia in Newborn Infants
Brief Summary: Guidelines on neonatal resuscitation recommend 90 chest compressions (CC) and 30 manual inflations (3:1) per minute in newborns. The study aimed to determine if CC s during sustained inflations (SI) improves recovery of asphyxiated newborns compared to coordinated 3:1 resuscitation.


Options:
A: Arm Label: "SI group"; Type: EXPERIMENTAL; Interventions: Procedure: SI group | Arm Label: IPPV group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: "IPPV group" | Intervention Type: PROCEDURE; Name: "IPPV group"; Assigned to Arm(s): IPPV group | Intervention Type: PROCEDURE; Name: SI group; Assigned to Arm(s): "SI group"
B: Arm Label: Control Arm-Standard of care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard of Care | Arm Label: Sustained Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Sustained Inflation | Intervention Type: PROCEDURE; Name: Sustained Inflation; Assigned to Arm(s): Sustained Intervention | Intervention Type: PROCEDURE; Name: Standard of Care; Assigned to Arm(s): Control Arm-Standard of care
C: Arm Label: SI+CC; Type: EXPERIMENTAL; Interventions: Procedure: CC+SI | Arm Label: 3:1 CPR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: 3:1 CPR | Intervention Type: PROCEDURE; Name: CC+SI; Assigned to Arm(s): SI+CC | Intervention Type: PROCEDURE; Name: 3:1 CPR; Assigned to Arm(s): 3:1 CPR
D: Arm Label: Intervention (CC+SI); Type: EXPERIMENTAL; Interventions: Procedure: CC+SI | Arm Label: Control (3:1 C:V); Type: ACTIVE_COMPARATOR; Interventions: Procedure: 3:1 C:V | Intervention Type: PROCEDURE; Name: CC+SI; Assigned to Arm(s): Intervention (CC+SI) | Intervention Type: PROCEDURE; Name: 3:1 C:V; Assigned to Arm(s): Control (3:1 C:V)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Single Center Prospective Randomized Control Trial on Negative Pressure Wound Therapy for Primarily Closed Groin Incisions Following Lower-limb Re-vascularization to Reduce Surgical Site Infection
Brief Summary: The purpose of this study is to investigate the current standard of wound care following vascular operations compared to to a negative pressure wound therapy (vacuum dressing) and the rate of surgical site infections (SSIs) in patients undergoing surgery to restore blood flow to the lower limb(s).

Negative pressure wound therapy consists of a closed, sealed system that produces negative pressure (vacuum) to the wound surface. The device itself consists of open-cell foam that is sealed with an occlusive adhesive dressing (covers and sticks to the incision) and suction is maintained by connecting suction tubes to a vacuum pump and waste collector.

The investigators objectives are to determine whether there will be any reduction in surgical site infection and this potential reduction will influence length of hospital stay, emergency room visits, antibiotic use and need for re-operation.


Options:
A: Arm Label: Dry Dressing; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: V.A.C. by K.C.I. | Intervention Type: DEVICE; Name: V.A.C. by K.C.I.; Assigned to Arm(s): Negative Pressure Wound Therapy
B: Arm Label: Vacuum assisted closure; Type: EXPERIMENTAL; Interventions: Procedure: vacuum assisted closure | Arm Label: Axillary dissection; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Axillary dissection | Intervention Type: PROCEDURE; Name: vacuum assisted closure; Assigned to Arm(s): Vacuum assisted closure | Intervention Type: PROCEDURE; Name: Axillary dissection; Assigned to Arm(s): Axillary dissection
C: Arm Label: Current Standard; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Prevena (Negative Pressure Wound Therapy Device) | Intervention Type: DEVICE; Name: Prevena (Negative Pressure Wound Therapy Device); Assigned to Arm(s): Negative Pressure Wound Therapy | Intervention Type: DEVICE; Name: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing; Assigned to Arm(s): Current Standard
D: Arm Label: Vacuum-assisted closure (VAC); Type: EXPERIMENTAL; Interventions: Device: Vacuum-assisted closure | Arm Label: Standard sterile dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard sterile dressing | Intervention Type: DEVICE; Name: Vacuum-assisted closure; Assigned to Arm(s): Vacuum-assisted closure (VAC) | Intervention Type: DEVICE; Name: Standard sterile dressing; Assigned to Arm(s): Standard sterile dressing

Answer: C